Loading…
Olaplex Holdings, Inc.
NASDAQ: OLPX Consumer Discretionary Consumer 🔎 Screen
$1.4B
Market Cap
57.7
P/E
1.29
PEG
1.8%
ROCE
-1.1%
ROE
0.41
D/E
3.8%
OPM
0.0%
% from 52W High
76
α RS
🔍 OLPX is showing a near-52W-high setup because it's within 0% of its 52-week high and RS Rating is 76. Net: Partial signal stack, not a recommendation. ? 52W High RS Rating
Sources
0% from 52W high · RS Rating 76
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for OLPX including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Olaplex Holdings, Inc., through its subsidiaries, develops, manufactures, and sells haircare products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It also provides in-salon services for repairing and shaping curls. The company distributes its products through professional distributors in salons, directly to retailers for sale in their physical stores, e-commerce sites, and its website, as well as third party e-commerce platforms. Olaplex Holdings, Inc. was founded in 2014 and is based in New York, New York.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding OLPX
View All Superinvestors →
Manager Shares Value % of Fund Period
Jim Simons Renaissance Technologies LLC 3.27M $6.6M 0.01% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
📊 MIXED Olaplex flat revenue $423M in 2025, Q4 growth 4%, EBITDA margin 22.2%
Revenue & Profitability
Full year 2025 net sales were $423.0 million, flat year-over-year. Fourth-quarter net sales rose 4.3% to $105.1 million. Adjusted EBITDA for the year was $93.9 million (22.2% margin) and $12.9 million (12.2% margin) in Q4. The company generated operating cash flow of $58.7 million in fiscal 2025.
Outlook
Management cites Euromonitor data forecasting premium haircare growth of 6-7% through 2029, with premium haircare currently representing only 20% of the total market. They note potential headwinds from an uncertain global macroeconomic environment and shifting consumer sentiment. The company expects sell-through to improve sequentially and turn positive for the full year 2026.
Growth Drivers
Key growth levers include energizing hero products like the new Nº.3PLUS launch, fueling science-based innovation with a multi-year pipeline, and expanding the go-to-market model through professional channel momentum, deeper retail partnerships, and disciplined international expansion. The company also plans to scale TikTok Shop and optimize promotional activities.
Balance Sheet & CapEx
Not discussed in this earnings call.
Margins
Fiscal 2025 adjusted gross margin improved 40 basis points to 71.8%, while adjusted EBITDA margin declined to 22.2% due to strategic investments. For 2026, the company guides adjusted gross profit margin of 71-72% and adjusted EBITDA margin of 21-22%. First-quarter EBITDA will be significantly pressured as marketing spend is front-loaded for Nº.3PLUS, with efficiency improving thereafter.
Key Risks
Management flagged potential risks from tariffs (though minimal exposure assumed), geopolitical disruptions, and the non-linear nature of the transformation. They also cited operational complexity from the packaging rollout and the uncertain pace of sell-through recovery, which could affect the ability to hit the high end of the revenue guidance range (-2% to +3%).
Generated by AI · Q4 2025 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q4 2025 Q4 2025 2026-03-05
FY 2025 saw stabilized sales and margin improvement, with Q4 revenue up 4% year-over-year and strong professional channel growth. 2026 guidance anticipates flat to modest sales growth, continued margin strength, and sequential improvement as new innovations and marketing investments take effect.
Q3 2025 Q3 2025 2025-11-06
Q3 results exceeded expectations with strong execution in new product launches and marketing, despite a 3.8% year-over-year sales decline. Guidance for 2025 is reaffirmed, with ongoing investments in brand, innovation, and international growth amid a challenging macro environment.
Q2 2025 Q2 2025 2025-08-07
Q2 2025 net sales rose 2.3% YoY to $106.3M, with strong direct-to-consumer and professional growth offsetting retail declines. Transformation efforts and increased marketing spend are driving brand health, while full-year guidance is maintained amid ongoing operational improvements.
Q1 2025 Q1 2025 2025-05-08
First quarter net sales declined 1.9% year over year to $97 million but exceeded expectations, driven by strong specialty retail growth and early benefits from brand transformation. Adjusted EBITDA margin was 26.5%, and 2025 guidance was reaffirmed, with increased marketing investment and a significant debt reduction post-quarter.
Q4 2024 Q4 2024 2025-03-04
2024 saw a strategic transformation with net sales and adjusted EBITDA declining year-over-year, but strong cash flow and progress on innovation and brand repositioning. FY2025 guidance anticipates flat to modest sales growth, with continued investment in marketing and talent to drive long-term profitability.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.